New York, NY – May 6, 2025 – SkinIO is proud to announce that Chief Marketing Officer Kathryn Rooks, MBA will represent the company at the MSK Direct Benefits Leaders’ Summit in New York City during the Innovator Spotlight: Breakthroughs in Early Cancer Detection.
As part of this prestigious panel, Kathryn will showcase how SkinIO’s AI-powered skin cancer screening platform—combined with its expedited access to dermatological care—helps deliver faster diagnoses, improved clinical outcomes, and better quality of life for patients. The discussion will also explore how this tech-enabled approach supports employers in building healthier, more productive teams.
“SkinIO is transforming the way we detect skin cancer—making it faster, easier, and more accessible,” said Rooks. “Just as importantly, our expedited care model ensures that patients receive the follow-up they need without unnecessary delays, which ultimately leads to better outcomes and healthier lives.”
Key benefits of SkinIO’s approach include:
· Earlier detection and intervention
· Reduced time to treatment
· Increased workplace productivity
· Enhanced quality of life for patients and their families
This appearance marks a meaningful moment in SkinIO’s continued effort to shift the paradigm from reactive to proactive healthcare, especially in the fight against the fastest-growing cancer in the U.S.
We are honored to be part of this important conversation and grateful to MSK Direct for spotlighting the innovators driving the future of early cancer detection.
About SkinIO
SkinIO is a mission-driven health technology company dedicated to saving lives through early skin cancer detection. Our patented AI-powered app enables fast, accessible skin screenings, while our expedited access-to-care model ensures patients connect with dermatologists quickly and seamlessly. Learn more at www.skinio.com.
